New CRISPR Clinical Trial

GenomeWeb 28 April 2017

Chinese researchers are starting a clinical trial investigating use of CRISPR/Cas9 in cancer therapy.  Patients with aggressive gastric cancer, nasopharyngeal carcinoma, and lymphoma will have their own modified immune cells reinjected in the hope that they will target and destroy cancer cells.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply